Stay updated on Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial page.

Latest updates to the Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe Locations section was updated to add Illinois, Michigan, New York, Ohio, and Tennessee locations and remove the previous location blocks, with a revision tag indicating v3.3.3.SummaryDifference0.6%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page update shows an added Revision: v3.3.2 and a removed Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedThe government funding status banner on the page was removed, reducing visibility of a maintenance notice; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check59 days agoChange DetectedResults for NCT03242915 have been posted, including the primary endpoint (response rate) and secondary endpoints (progression-free survival and overall survival). The study record dates reflect updates and results submission in May 2025.SummaryDifference0.4%

- Check88 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. Overall, the page now communicates current operating status and version, indicating a substantive update.SummaryDifference4%

- Check95 days agoChange DetectedUpdate: version bumped from v3.0.2 to v3.1.0, reflecting a new revision tag on the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial page.